My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.123 -0.046 (-2.14%)

Streaming Delayed Price Updated: 2:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Cassava Stock Dives Again As Lab Distances Itself From 'Data Manipulation' Allegations ↗

August 27, 2021

The lab that tested samples for Cassava's Alzheimer's study distanced itself from the biotech Friday, and SAVA stock plunged again.

Via Investor's Business Daily

Why Cassava Sciences Stock Investors Are Pulling Back ↗

August 27, 2021

The neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) hasnow lost half of its market capitalization as skeletons continue to tumble out of...

Via Benzinga

Which Biotech Stock Will Shock the Market in 2022? ↗

August 27, 2021

Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?

Via The Motley Fool

Mid-Morning Market Update: Markets Open Higher; Big Lots Reports Downbeat Profit ↗

August 27, 2021

Following the market opening Friday, the Dow traded up 0.30% to 35,320.11 while the NASDAQ rose 0.27% to 14,986.36. The S&P also rose, gaining 0.33% to 4,484.57. The U.S. has...

Via Benzinga

Topics Stocks

63 Biggest Movers From Yesterday ↗

August 27, 2021

Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11...

Via Benzinga

Why Traders Shouldn’t Bargain Hunt in Cassava Stock ↗

August 26, 2021

Wall Street is notorious for its overreactions, but when it comes to SAVA stock's cratering, investors consider other historical precedents.

Via InvestorPlace

As Allegations Swirl, Can Investors Still Count on Cassava Sciences Stock? ↗

August 26, 2021

This once-promising biotech is now struggling to stay afloat.

Via The Motley Fool

Better Biotech Stock: Cassava Sciences vs. Annovis Bio ↗

August 26, 2021

It boils down to which company's clinical trial results look better for treating Alzheimer's at the moment.

Via The Motley Fool

GameStop Continues To See Sky-High WallStreetBets Interest; AMC, BlackBerry, Alibaba, Palantir Are Other Top Trends ↗

August 25, 2021

GameStop Corp. (NYSE:GME) continued to be the most-discussed ...

Via Benzinga

SAVA Stock: Cassava Sciences Sinks Despite Countering Trial Data Allegations ↗

August 25, 2021

Today, investors in Cassava Sciences and SAVA stock are seeing a lot of red, as investors digest a statement of concern filed yesterday.

Via InvestorPlace

54 Biggest Movers From Yesterday ↗

August 26, 2021

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently...

Via Benzinga

Mid-Afternoon Market Update: Dow Rises 100 Points; ScanSource Shares Surge Following Q4 Results ↗

August 25, 2021

Toward the end of trading Wednesday, the Dow traded up 0.30% to 35,470.78 while the NASDAQ rose 0.12% to 15,038.45. The S&P also rose, gaining 0.28% to 4,498.64. The U.S. has...

Via Benzinga

Topics Stocks

S&P 500, Nasdaq Extend Records on Delta Variant Decline ↗

August 25, 2021

The S&P 500 Index and Nasdaq Composite are on the rise midday, extending yesterday's record closes and nabbing fresh intraday highs.

Via Talk Markets

Topics Stocks

2 Little-Known Nasdaq Stocks Making Big Moves Wednesday ↗

August 25, 2021

Don't let these companies fly under your radar.

Via The Motley Fool

Topics Stocks

SAVA Stock: The Allegations That Have Cassava Sciences Sinking Today ↗

August 25, 2021

Shares of SAVA stock are crashing on Wednesday after allegations about Cassava Sciences' Alzheimer's disease treatment are being reviewed.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 25, 2021

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell Bioscience's stock is trading at a volume of 8...

Via Benzinga

Mid-Day Market Update: Gold Down 1%; Locust Walk Acquisition Shares Jump ↗

August 25, 2021

Midway through trading Wednesday, the Dow traded up 0.20% to 35,435.82 while the NASDAQ rose 0.05% to 15,027.49. The S&P also rose, gaining 0.14% to 4,492.54. The U.S. has the...

Via Benzinga

Topics Stocks

36 Stocks Moving In Wednesday's Mid-Day Session ↗

August 25, 2021

Gainers Locust Walk Acquisition Corp. (NASDAQ: LWAC) shares jumped 188% to $25.34 after the company announced stockholders approved a business combination with eFFECTOR...

Via Benzinga

Here's Why Cassava Sciences Is Having a Bad Day ↗

August 25, 2021

The FDA received a citizen petition requesting a halt to clinical trials with the company's Alzheimer's disease candidate.

Via The Motley Fool

Mid-Morning Market Update: Markets Edge Higher; Dick's Sporting Goods Beats Q2 Views ↗

August 25, 2021

Following the market opening Wednesday, the Dow traded up 0.07% to 35,389.32 while the NASDAQ rose 0.17% to 15,045.45. The S&P also rose, gaining 0.14% to 4,492.57. The U.S....

Via Benzinga

Topics Stocks

Cassava Sciences Stock Shows Promise With Simufilam Trials Drawing Near ↗

August 25, 2021

SAVA stock is up as the company announced the FDA has agreed on study protocols for Phase 3 clinical trials of Simufilam.

Via InvestorPlace

Cassava Stock Plummets On Claims Of 'Data Manipulation' In Alzheimer's Testing ↗

August 25, 2021

A shareholder firm called for the FDA to halt Cassava Sciences' studies in Alzheimer's disease, leading SAVA stock to plummet Wednesday.

Via Investor's Business Daily

Cassava Sciences Shares Sink With Alzheimer's Drug Mired In Controversy ↗

August 25, 2021

Neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) saw both sides of the world Tuesday. The stock rallied to close higher by 2% after it announced...

Via Benzinga

Why Cassava Sciences' Stock Is Getting Hammered Today ↗

August 25, 2021

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading lower on negative claims that were posted online yesterday after market hours. The company issued a response to the claims...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 25, 2021

Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 25.49% to $19.2 during Wednesday's pre-market session. The company's market cap stands at $242.7...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug ↗

August 25, 2021

ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

21 Stocks Moving in Wednesday's Pre-Market Session ↗

August 25, 2021

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on Tuesday. Regencell Bioscience recently reported...

Via Benzinga

Cassava Sciences Has an Admirable Goal at Too High a Price ↗

August 24, 2021

It would be great if Cassava Sciences' treatment for Alzheimer's disease worked, but should you pay the high price for SAVA stock? No.

Via InvestorPlace

Cassava Sciences Receives FDA's Special Protocol Assessment For Alzheimer's Trials ↗

August 24, 2021

Cassava Sciences Inc (NASDAQ: SAVA) announced an agreement with the FDA under a Special Protocol Assessment (SPA) for both of its pivotal Phase 3 trials for oral...

Via Benzinga

Soaring Cassava Sciences Stock Shows Unfettered Promise for Growth ↗

August 20, 2021

With more than 6 million people in the U.S. suffering from Alzheimer's disease, SAVA stock has enormous potential for future profits.

Via InvestorPlace

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.